nodes	percent_of_prediction	percent_of_DWPC	metapath
Etoposide—uterine cancer—fallopian tube cancer	0.55	0.584	CtDrD
Etoposide—germ cell cancer—fallopian tube cancer	0.392	0.416	CtDrD
Etoposide—GSTT1—female reproductive system—fallopian tube cancer	0.00218	0.0379	CbGeAlD
Etoposide—TOP2B—uterine cervix—fallopian tube cancer	0.00215	0.0373	CbGeAlD
Etoposide—TOP2B—endometrium—fallopian tube cancer	0.00194	0.0337	CbGeAlD
Etoposide—TOP2B—uterus—fallopian tube cancer	0.00179	0.0311	CbGeAlD
Etoposide—TOP2B—female reproductive system—fallopian tube cancer	0.00161	0.0279	CbGeAlD
Etoposide—TOP2A—uterine cervix—fallopian tube cancer	0.00158	0.0274	CbGeAlD
Etoposide—TOP2B—female gonad—fallopian tube cancer	0.00146	0.0254	CbGeAlD
Etoposide—TOP2B—vagina—fallopian tube cancer	0.00145	0.0252	CbGeAlD
Etoposide—TOP2A—endometrium—fallopian tube cancer	0.00143	0.0248	CbGeAlD
Etoposide—GSTP1—epithelium—fallopian tube cancer	0.00136	0.0235	CbGeAlD
Etoposide—GSTP1—uterine cervix—fallopian tube cancer	0.00134	0.0233	CbGeAlD
Etoposide—ABCC10—uterine cervix—fallopian tube cancer	0.00134	0.0233	CbGeAlD
Etoposide—TOP2A—uterus—fallopian tube cancer	0.00132	0.0228	CbGeAlD
Etoposide—GSTP1—endometrium—fallopian tube cancer	0.00122	0.0211	CbGeAlD
Etoposide—ABCC10—endometrium—fallopian tube cancer	0.00122	0.0211	CbGeAlD
Etoposide—GSTP1—uterus—fallopian tube cancer	0.00112	0.0195	CbGeAlD
Etoposide—ABCC10—uterus—fallopian tube cancer	0.00112	0.0194	CbGeAlD
Etoposide—TOP2A—female gonad—fallopian tube cancer	0.00108	0.0187	CbGeAlD
Etoposide—TOP2A—vagina—fallopian tube cancer	0.00107	0.0186	CbGeAlD
Etoposide—ABCC3—female reproductive system—fallopian tube cancer	0.00101	0.0176	CbGeAlD
Etoposide—GSTP1—female reproductive system—fallopian tube cancer	0.00101	0.0175	CbGeAlD
Etoposide—ABCC10—female reproductive system—fallopian tube cancer	0.00101	0.0175	CbGeAlD
Etoposide—ABCC1—uterine cervix—fallopian tube cancer	0.00095	0.0165	CbGeAlD
Etoposide—ABCC3—female gonad—fallopian tube cancer	0.00092	0.016	CbGeAlD
Etoposide—GSTP1—female gonad—fallopian tube cancer	0.000916	0.0159	CbGeAlD
Etoposide—ABCC10—female gonad—fallopian tube cancer	0.000916	0.0159	CbGeAlD
Etoposide—GSTP1—vagina—fallopian tube cancer	0.000911	0.0158	CbGeAlD
Etoposide—ABCC10—vagina—fallopian tube cancer	0.00091	0.0158	CbGeAlD
Etoposide—ABCC1—endometrium—fallopian tube cancer	0.000859	0.0149	CbGeAlD
Etoposide—ABCC2—female reproductive system—fallopian tube cancer	0.000808	0.014	CbGeAlD
Etoposide—ABCC1—uterus—fallopian tube cancer	0.000792	0.0137	CbGeAlD
Etoposide—ABCG2—uterine cervix—fallopian tube cancer	0.000787	0.0137	CbGeAlD
Etoposide—CYP2C8—endometrium—fallopian tube cancer	0.000732	0.0127	CbGeAlD
Etoposide—CYP3A5—uterine cervix—fallopian tube cancer	0.00073	0.0127	CbGeAlD
Etoposide—ABCG2—endometrium—fallopian tube cancer	0.000711	0.0124	CbGeAlD
Etoposide—PTGS1—epithelium—fallopian tube cancer	0.000662	0.0115	CbGeAlD
Etoposide—PTGS1—uterine cervix—fallopian tube cancer	0.000656	0.0114	CbGeAlD
Etoposide—ABCG2—uterus—fallopian tube cancer	0.000656	0.0114	CbGeAlD
Etoposide—ABCC1—female gonad—fallopian tube cancer	0.000648	0.0112	CbGeAlD
Etoposide—ABCC1—vagina—fallopian tube cancer	0.000644	0.0112	CbGeAlD
Etoposide—PTGS2—epithelium—fallopian tube cancer	0.000632	0.011	CbGeAlD
Etoposide—PTGS2—uterine cervix—fallopian tube cancer	0.000627	0.0109	CbGeAlD
Etoposide—CYP2C8—female reproductive system—fallopian tube cancer	0.000606	0.0105	CbGeAlD
Etoposide—PTGS1—endometrium—fallopian tube cancer	0.000593	0.0103	CbGeAlD
Etoposide—PTGS2—endometrium—fallopian tube cancer	0.000567	0.00985	CbGeAlD
Etoposide—CYP2C8—vagina—fallopian tube cancer	0.000548	0.00952	CbGeAlD
Etoposide—PTGS1—uterus—fallopian tube cancer	0.000547	0.00949	CbGeAlD
Etoposide—ABCG2—female gonad—fallopian tube cancer	0.000536	0.00931	CbGeAlD
Etoposide—ABCG2—vagina—fallopian tube cancer	0.000533	0.00925	CbGeAlD
Etoposide—PTGS2—uterus—fallopian tube cancer	0.000523	0.00907	CbGeAlD
Etoposide—CYP2E1—female reproductive system—fallopian tube cancer	0.00051	0.00886	CbGeAlD
Etoposide—CYP3A5—female gonad—fallopian tube cancer	0.000498	0.00864	CbGeAlD
Etoposide—CYP3A5—vagina—fallopian tube cancer	0.000495	0.00859	CbGeAlD
Etoposide—PTGS1—female reproductive system—fallopian tube cancer	0.000492	0.00853	CbGeAlD
Etoposide—PTGS2—female reproductive system—fallopian tube cancer	0.00047	0.00816	CbGeAlD
Etoposide—PTGS1—female gonad—fallopian tube cancer	0.000447	0.00777	CbGeAlD
Etoposide—PTGS1—vagina—fallopian tube cancer	0.000445	0.00772	CbGeAlD
Etoposide—PTGS2—female gonad—fallopian tube cancer	0.000428	0.00742	CbGeAlD
Etoposide—PTGS2—vagina—fallopian tube cancer	0.000425	0.00738	CbGeAlD
Etoposide—CYP3A4—female reproductive system—fallopian tube cancer	0.000411	0.00713	CbGeAlD
Etoposide—ABCB1—epithelium—fallopian tube cancer	0.000391	0.00679	CbGeAlD
Etoposide—ABCB1—uterine cervix—fallopian tube cancer	0.000388	0.00673	CbGeAlD
Etoposide—ABCB1—endometrium—fallopian tube cancer	0.000351	0.00609	CbGeAlD
Etoposide—ABCB1—uterus—fallopian tube cancer	0.000323	0.00561	CbGeAlD
Etoposide—ABCB1—female reproductive system—fallopian tube cancer	0.000291	0.00505	CbGeAlD
Etoposide—ABCB1—female gonad—fallopian tube cancer	0.000264	0.00459	CbGeAlD
Etoposide—ABCB1—vagina—fallopian tube cancer	0.000263	0.00456	CbGeAlD
